These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 640328)

  • 41. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse.
    Ossowski L; Russo-Payne H; Wilson EL
    Cancer Res; 1991 Jan; 51(1):274-81. PubMed ID: 1988089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on coagulation and fibrinolysis. III. Urokinase activated fibrinolysodynamicogram].
    Hu YM; Xue H; Wang KQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Jun; 4(3):133-6. PubMed ID: 6215134
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].
    Páramo JA; Fernández FJ; Cuesta B; Paloma MJ; Rocha E
    Sangre (Barc); 1989 Aug; 34(4):297-9. PubMed ID: 2505395
    [No Abstract]   [Full Text] [Related]  

  • 44. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.
    Kurokawa T; Iwasa S; Kakinuma A; Stassen JM; Lijnen HR; Collen D
    Thromb Haemost; 1991 Dec; 66(6):684-93. PubMed ID: 1796414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro potentiation of urokinase-activated lysis of human fibrin clots.
    Singh K; Vézina C
    J Med; 1974; 5(6):297-302. PubMed ID: 4528600
    [No Abstract]   [Full Text] [Related]  

  • 46. [New method of studying the release of fibrinolysis activators in tissue cultures].
    Pandolfi M; Astedt B
    Biull Eksp Biol Med; 1977 Aug; 84(8):250-3. PubMed ID: 907833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
    Yu HR; Schultz RM
    Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation.
    Schermuly RT; Günther A; Ermert M; Ermert L; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Walmrath D
    Am J Physiol Lung Cell Mol Physiol; 2001 Apr; 280(4):L792-800. PubMed ID: 11238021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urokinase immobilized on medical polymeric materials: fundamental and clinical studies.
    Ohshiro T; Kosaki G
    Artif Organs; 1980 Feb; 4(1):58-4. PubMed ID: 6989347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to plasminogen activator inhibit human tumor metastasis.
    Ossowski L; Reich E
    Cell; 1983 Dec; 35(3 Pt 2):611-9. PubMed ID: 6418388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factor XIII cross-linking and the rate of fibrinolysis induced by streptokinase and urokinase.
    Rampling MW
    Thromb Res; 1978 Feb; 12(2):287-95. PubMed ID: 635844
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative study of different urokinase preparations.
    Millar WT; Smith JF
    Thromb Res; 1983 Jun; 30(5):425-9. PubMed ID: 6351343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fate of intravenously injected cultured human cancer cells in the lungs of congenitally athymic nude mice.
    Naito S; Kinjo M; Tanaka K
    Acta Pathol Jpn; 1980 Jul; 30(4):541-7. PubMed ID: 7415836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Threshold phenomena in blood fibrinolysis.
    Matsuo O; Mihara H
    Thromb Res; 1977 May; 10(5):753-8. PubMed ID: 882961
    [No Abstract]   [Full Text] [Related]  

  • 56. Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits.
    Idell S; Allen T; Chen S; Koenig K; Mazar A; Azghani A
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L25-32. PubMed ID: 16980376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of dextran on the fibrinolytic activity of urokinase.
    Matsuo O; Kosugi T; Mihara H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):112-8. PubMed ID: 6180584
    [No Abstract]   [Full Text] [Related]  

  • 58. Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues.
    Ornstein DL; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Hunt J; Rousseau SM; Stump DC
    Cancer; 1991 Sep; 68(5):1061-7. PubMed ID: 1913476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on mechanisms involved in metastasis formation from circulating tumor cells. Factors influencing tumor cell lodgement during normal and post-traumatic conditions.
    Skolnik G; Alpsten M; Ivarsson L
    J Cancer Res Clin Oncol; 1980; 97(3):249-56. PubMed ID: 7440626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urokinase exerts antimetastatic effects by dissociating clusters of circulating tumor cells.
    Choi JW; Kim JK; Yang YJ; Kim P; Yoon KH; Yun SH
    Cancer Res; 2015 Nov; 75(21):4474-82. PubMed ID: 26527605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.